AU4451797A - 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds - Google Patents
3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compoundsInfo
- Publication number
- AU4451797A AU4451797A AU44517/97A AU4451797A AU4451797A AU 4451797 A AU4451797 A AU 4451797A AU 44517/97 A AU44517/97 A AU 44517/97A AU 4451797 A AU4451797 A AU 4451797A AU 4451797 A AU4451797 A AU 4451797A
- Authority
- AU
- Australia
- Prior art keywords
- alkoxyisoxazol
- substituted
- carboxylic acid
- acid compounds
- amino carboxylic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK1092/96 | 1996-10-04 | ||
DK109296 | 1996-10-04 | ||
PCT/DK1997/000426 WO1998015542A1 (en) | 1996-10-04 | 1997-10-03 | 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4451797A true AU4451797A (en) | 1998-05-05 |
AU733004B2 AU733004B2 (en) | 2001-05-03 |
Family
ID=8100908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44517/97A Ceased AU733004B2 (en) | 1996-10-04 | 1997-10-03 | 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
Country Status (26)
Country | Link |
---|---|
US (1) | US6200999B1 (en) |
EP (1) | EP0934286B1 (en) |
JP (1) | JP2001501630A (en) |
KR (1) | KR20000048908A (en) |
CN (1) | CN1238766A (en) |
AR (1) | AR008880A1 (en) |
AT (1) | ATE230734T1 (en) |
AU (1) | AU733004B2 (en) |
BG (1) | BG103348A (en) |
BR (1) | BR9712198A (en) |
CA (1) | CA2268028C (en) |
CZ (1) | CZ116899A3 (en) |
DE (1) | DE69718338T2 (en) |
EA (1) | EA001625B1 (en) |
ES (1) | ES2189978T3 (en) |
HU (1) | HUP0000084A3 (en) |
IL (1) | IL129135A0 (en) |
IS (1) | IS5009A (en) |
NO (1) | NO312961B1 (en) |
NZ (1) | NZ334798A (en) |
PL (1) | PL332553A1 (en) |
SK (1) | SK42899A3 (en) |
TR (1) | TR199900724T2 (en) |
UA (1) | UA52698C2 (en) |
WO (1) | WO1998015542A1 (en) |
ZA (1) | ZA978877B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA73749C2 (en) * | 1999-11-01 | 2005-09-15 | Diarylenines | |
ES2269458T3 (en) * | 2000-09-15 | 2007-04-01 | Vertex Pharmaceuticals Incorporated | ISOXAZOLES AND ITS USE AS INHIBITORS OF THE ERK. |
US20040106794A1 (en) * | 2001-04-16 | 2004-06-03 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
UA78529C2 (en) * | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
MXPA05010760A (en) | 2003-04-09 | 2005-12-12 | Wyeth Corp | Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists. |
TW200514775A (en) | 2003-10-22 | 2005-05-01 | Wyeth Corp | Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof |
EP1937674A1 (en) * | 2005-10-11 | 2008-07-02 | F.Hoffmann-La Roche Ag | Isoxazole derivatives |
US8722714B2 (en) | 2008-01-16 | 2014-05-13 | The Honk Kong University of Science and Technology | Oxazolidine derivatives as NMDA antagonists |
EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
TW201609719A (en) | 2014-05-28 | 2016-03-16 | 美國禮來大藥廠 | 6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists |
US10442768B2 (en) | 2016-01-21 | 2019-10-15 | Agro-Kanesho Co., Ltd. | Method for producing 2-aminonicotinic acid benzyl ester derivative |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0456519T3 (en) | 1990-05-11 | 1994-11-07 | Sankyo Co | Piperidyloxy and quinuclidinyloxyisoxazole derivatives, their preparation and their therapeutic use |
ATE182139T1 (en) | 1992-10-23 | 1999-07-15 | Merck Sharp & Dohme | DOPAMINE RECEPTOR SUBTYPE LIGANDS |
DK124393D0 (en) * | 1993-11-03 | 1993-11-03 | Lundbeck & Co As H | COMPOUNDS |
-
1997
- 1997-03-10 UA UA99042300A patent/UA52698C2/en unknown
- 1997-10-03 EA EA199900358A patent/EA001625B1/en not_active IP Right Cessation
- 1997-10-03 PL PL97332553A patent/PL332553A1/en unknown
- 1997-10-03 SK SK428-99A patent/SK42899A3/en unknown
- 1997-10-03 ZA ZA9708877A patent/ZA978877B/en unknown
- 1997-10-03 ES ES97942821T patent/ES2189978T3/en not_active Expired - Lifetime
- 1997-10-03 NZ NZ334798A patent/NZ334798A/en unknown
- 1997-10-03 AT AT97942821T patent/ATE230734T1/en not_active IP Right Cessation
- 1997-10-03 AR ARP970104586A patent/AR008880A1/en not_active Application Discontinuation
- 1997-10-03 TR TR1999/00724T patent/TR199900724T2/en unknown
- 1997-10-03 BR BR9712198-3A patent/BR9712198A/en unknown
- 1997-10-03 DE DE69718338T patent/DE69718338T2/en not_active Expired - Fee Related
- 1997-10-03 IL IL12913597A patent/IL129135A0/en unknown
- 1997-10-03 EP EP97942821A patent/EP0934286B1/en not_active Expired - Lifetime
- 1997-10-03 CA CA002268028A patent/CA2268028C/en not_active Expired - Fee Related
- 1997-10-03 HU HU0000084A patent/HUP0000084A3/en unknown
- 1997-10-03 AU AU44517/97A patent/AU733004B2/en not_active Ceased
- 1997-10-03 KR KR1019990702938A patent/KR20000048908A/en not_active Application Discontinuation
- 1997-10-03 JP JP10517096A patent/JP2001501630A/en active Pending
- 1997-10-03 WO PCT/DK1997/000426 patent/WO1998015542A1/en not_active Application Discontinuation
- 1997-10-03 CN CN97180167A patent/CN1238766A/en active Pending
- 1997-10-03 US US09/269,356 patent/US6200999B1/en not_active Expired - Fee Related
- 1997-10-03 CZ CZ991168A patent/CZ116899A3/en unknown
-
1999
- 1999-03-20 BG BG103348A patent/BG103348A/en unknown
- 1999-03-23 IS IS5009A patent/IS5009A/en unknown
- 1999-03-30 NO NO19991561A patent/NO312961B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE230734T1 (en) | 2003-01-15 |
JP2001501630A (en) | 2001-02-06 |
KR20000048908A (en) | 2000-07-25 |
TR199900724T2 (en) | 1999-06-21 |
AU733004B2 (en) | 2001-05-03 |
CZ116899A3 (en) | 1999-09-15 |
NO991561D0 (en) | 1999-03-30 |
HUP0000084A2 (en) | 2000-06-28 |
WO1998015542A1 (en) | 1998-04-16 |
BR9712198A (en) | 1999-08-31 |
IS5009A (en) | 1999-03-23 |
EA199900358A1 (en) | 1999-10-28 |
PL332553A1 (en) | 1999-09-13 |
CN1238766A (en) | 1999-12-15 |
CA2268028C (en) | 2003-03-18 |
NO312961B1 (en) | 2002-07-22 |
ZA978877B (en) | 1998-04-17 |
SK42899A3 (en) | 1999-08-06 |
US6200999B1 (en) | 2001-03-13 |
EA001625B1 (en) | 2001-06-25 |
NZ334798A (en) | 2000-06-23 |
DE69718338D1 (en) | 2003-02-13 |
BG103348A (en) | 1999-11-30 |
NO991561L (en) | 1999-06-04 |
AR008880A1 (en) | 2000-02-23 |
EP0934286A1 (en) | 1999-08-11 |
EP0934286B1 (en) | 2003-01-08 |
UA52698C2 (en) | 2003-01-15 |
IL129135A0 (en) | 2000-02-17 |
DE69718338T2 (en) | 2003-10-16 |
CA2268028A1 (en) | 1998-04-16 |
HUP0000084A3 (en) | 2001-12-28 |
ES2189978T3 (en) | 2003-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4893993A (en) | Carboxylic acid derivatives | |
AU5703398A (en) | Novel compounds | |
AU6482398A (en) | Sulfonylaminocarboxylic acids | |
AU5230693A (en) | Carboxylic acid derivatives | |
AU2602297A (en) | Thickened acid composition | |
AU1942397A (en) | Fused-ring carboxylic acid derivatives | |
HU9401917D0 (en) | Propionic acid derivatives | |
AU1559199A (en) | Isothiazolcarboxylic acid derivatives | |
AU4451797A (en) | 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds | |
AU1364995A (en) | 5-vinyl- and 5-ethinyl-quinolone- carboxylic acids | |
AU7940598A (en) | Quinolone carboxylic acid derivatives | |
AU3093697A (en) | Aminophthalic acid derivatives | |
AU697025B2 (en) | Quinoline carboxylic acid | |
AU3443897A (en) | Glyoxylic acid derivatives | |
AU6926294A (en) | Carboxylic acid amide benzothiophene-s-oxides | |
AU5345798A (en) | Fructan-polycarboxylic acid | |
AU5423298A (en) | Novel compounds | |
HU9601167D0 (en) | 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds | |
AU4311096A (en) | Clavulanic acid salts | |
IL123213A0 (en) | Carboxylic acid derivatives | |
AU2629295A (en) | Trifluoromethylquinolinecarboxylic acid derivative | |
AU3711697A (en) | Novel compounds | |
AU5319898A (en) | Glyoxylic acid amides | |
SI0934286T1 (en) | 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds | |
AU8214498A (en) | Glyoxylic acid amides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |